ZO
Zota Health Care Ltd (ZOTA)
₹1,328.80
Mkt cap
₹4,602 Cr
P/E ratio
—
P/B
7.34
Div yield
0.08%
ROE
−15.00%
ROCE
−8.47%
EPS (TTM)
—
Book value
₹181
52W range
1,022–1,740
Sector
Healthcare
Price history
Previous close
Zota Health Care Limited is a renowned pharmaceutical company that manufactures, markets, and exports pharmaceutical, ayurvedic, nutraceutical, and over-the-counter (OTC) products across boundaries into the semi-regulated and regulated markets of Asian Countries markets of African Countries, Russian Countries & Latin America. [1]
NSE ZOTA
Health check
Mixed
ProfitabilityWeak
GrowthHigh
TechnicalsNeutral
52-week range
−23.63% from high₹1,329
₹1,022+30.02% from low₹1,740
Current
₹1,328.80
Prev close
₹1,323.60
Day
+0.39%
Price performance
1D
+0.03%
1W
+6.54%
1M
+1.83%
3M
+8.05%
6M
+0.88%
1Y
−14.14%
YTD
−13.90%
Financials
Revenue, profit & margin
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 45 | 47 | 50 | 56 | 67 | 72 | 97 | 104 | 129 | 143 | 163 | 174 | 199 | |
| Expenses | 41 | 44 | 51 | 58 | 68 | 78 | 95 | 100 | 123 | 143 | 154 | 185 | 196 | |
| Operating Profit | 4 | 3 | -1 | -1 | -1 | -6 | 2 | 4 | 6 | -0 | 9 | -12 | 3 | |
| OPM % | 10% | 7% | -3.0% | -2.2% | -1.3% | -8% | 2.5% | 3.8% | 4.9% | -0.3% | 5% | -7% | 1.5% | |
| Other Income | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 2 | -3 | 2 | 5 | |
| Interest | 1 | 1 | 2 | 3 | 3 | 2 | 3 | 3 | 4 | 5 | 5 | 6 | 6 | |
| Depreciation | 5 | 5 | 7 | 8 | 10 | 11 | 14 | 15 | 19 | 22 | 27 | 28 | 29 | |
| Profit before tax | -1 | -3 | -10 | -12 | -13 | -18 | -14 | -13 | -14 | -26 | -26 | -44 | -27 | |
| Tax % | 49% | 7% | -27% | 5% | -4% | 2% | -10% | 5% | 13% | 14% | -45% | 1% | -4% | |
| Net Profit | -2 | -3 | -7 | -13 | -12 | -19 | -13 | -14 | -16 | -30 | -14 | -44 | -26 | |
| EPS in Rs | -0.64 | -1.14 | -2.68 | -4.79 | -4.41 | -6.78 | -4.50 | -4.81 | -5.20 | -8.73 | -4.09 | -12.58 | -7.39 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
as of Sep 202649.38%Promoter
Promoters49.38%
FIIs6.92%1.00
DIIs7.30%0.55
Public36.40%0.44
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Sun Pharma.Inds. | ₹1,777.70 | 34.66 | 4,26,530 | 0.90% | 1,995 | −10.53% | 16,199 | +11.88% | 20.53% |
| Divi's Lab. | ₹9,780.00 | 87.14 | 2,59,628 | 0.31% | 902 | +65.50% | 3,080 | +27.80% | 21.97% |
| Torrent Pharma. | ₹4,613.40 | 80.83 | 1,75,479 | 0.82% | 534 | −10.03% | 4,979 | +50.79% | 15.19% |
| Laurus Labs | ₹2,405.50 | 97.00 | 1,29,972 | 0.08% | 436 | +126.43% | 2,206 | +33.44% | 17.76% |
| Zydus Lifesci. | ₹1,245.50 | 25.52 | 1,24,239 | 0.08% | 990 | −35.09% | 8,017 | +21.96% | 21.14% |
| Dr Reddy's Labs | ₹1,352.00 | 40.30 | 1,12,849 | 0.59% | 913 | −31.35% | 8,698 | −1.48% | 13.04% |
| Cipla | ₹1,378.90 | 35.87 | 1,11,397 | 0.94% | 852 | −35.05% | 7,404 | −2.44% | 15.49% |
| Zota Health Care | ₹1,328.80 | — | 4,602 | 0.08% | −26 | −60.38% | 199 | +54.58% | −8.47% |
| Median: 158 Co. | ₹426.38 | 34.39 | 1,921 | 0.08% | 14 | +22.08% | 175 | +18.92% | 15.12% |
Filings
Annual reports8
Concall transcripts38
RECOct 2026TranscriptAug 2026PPTAug 2026RECAug 2026TranscriptMay 2026PPTMay 2026TranscriptFeb 2026PPTFeb 2026TranscriptNov 2025PPTNov 2025RECNov 2025PPTOct 2025TranscriptAug 2025PPTAug 2025PPTJul 2025TranscriptJun 2025PPTJun 2025PPTApr 2025PPTFeb 2025PPTNov 2024PPTAug 2024PPTMay 2024PPTFeb 2024PPTNov 2023
Announcements5
Copy of Newspaper Publication 30 Oct - Published newspaper ads for Q2 and half-year FY2026 unaudited standalone and consolidated results on October 30, 2026.Analysts/Institutional Investor Meet/Con. Call Updates 29 Oct - Audio recording link shared for Q2 and half-year FY2026 earnings conference call held October 29, 2026.Statement of deviation(s) or variation(s) under Reg. 32 28 Oct - Zota Health Care reports no deviation in ₹34,999.99 lakh QIP proceeds for quarter ended September 30, 2026.Investor Presentation 28 Oct - Zota Health Care released Q2FY27 investor presentation covering operations, Davaindia expansion, exports and financial highlights.Press Release 28 Oct - Zota reported Q2FY27 revenue up 54.58% YoY, EBITDA ₹791.72 lakh, and 2,840 Davaindia stores.